E-ISSN 2149-388X | ISSN 2149-0430
 
2023, Vol: 9, Issue: 1
9/1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Form
Cover Letter
Title Page

Short Communication 


Epidemiology of HTLV1 Associated Lymphoma

Zahra Mozaheb.

Abstract
Introduction: In recent years, the incidence rates of many B-cell lymphomas have begun to decline in the United States, in contrast, incidence rates for T-cell lymphomas have continued to rise. T-cell lymphomas comprise multiple subtypes with different incidence rates and patterns that likely reflect their distinct etiologies. Incidence rates for lymphoid malignancies also vary by geography and there are some particular differences by subtypes. Human T-cell lymphotropic virus I (HTLV-1) which is endemic in Japan and the Caribbean, northeast of Iran, resulting in elevated rates of ATLs in these regions, but in non-endemic area such as North America Peripheral T cell lymphoma (PTCL) is the most common T cell lymphoma.
Conclusion: With multidisciplinary approaches to epidemiologic research, the major hurdles for uncovering T-cell lymphoma risk factors may finally be surmountable.

Key words: Lymphoma, HTLV1, Epidemiology


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Zahra Mozaheb
on Google
on Google Scholar


REFERENCES
1. Mozaheb Z. Epidemiology of Lymphoid Malignancy in Asia: Intech; 2012.
2. Boffetta P. I. Epidemiology of adult non-Hodgkin lymphoma. Annals of oncology. 2011;22(suppl 4):iv27-iv31. [DOI via Crossref]   
3. Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiology Biomarkers & Prevention. 2007;16(3):401-4. [DOI via Crossref]    [Pubmed]   
4. Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K. Peripheral T-cell lymphoma. Blood. 2011;117(25):6756-67. [DOI via Crossref]    [Pubmed]   
5. Harris ME. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-30. [DOI via Crossref]    [Pubmed]   
6. Tajima K. The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. International Journal of Cancer. 1990;45(2):237-43. [DOI via Crossref]    [Pubmed]   
7. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human Tlymphotropic virus type 1 among blood donors from Mashhad, Iran. Journal of clinical microbiology. 2003;41(6):2593-5. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
8. Mozaheb Z, Aledavood A, Farzad F. Distributions of major subtypes of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiology. 2011;35(1):26-9. [DOI via Crossref]    [Pubmed]   
9. Ohshima K, Suzumiya J, Kikuchi M. The World Health Organization classification of malignant lymphoma: Incidence and clinical prognosis in HTLV‐1‐endemic area of Fukuoka. Pathology international. 2002;52(1):1-12. [DOI via Crossref]    [Pubmed]   
10. De Th� G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS research and human retroviruses. 1993;9(5):381-6. [DOI via Crossref]   
11. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K-I, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proceedings of the National Academy of Sciences. 1981;78(10):6476-80. [DOI via Crossref]   
12. Morgan OS, Mora C, Rodgers-Johnson P, Char G. HTLV-1 and polymyositis in Jamaica. The Lancet. 1989;334(8673):1184-7. [DOI via Crossref]   
13. Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009;41(5):498-9. [DOI via Crossref]    [Pubmed]   
14. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Frontiers in microbiology. 2012;3:388. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
15. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki cohort study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 1996;13:S2-S7. [DOI via Crossref]   
16. Yamaguchi K. Human T-lymphotropic virus type I in Japan. The Lancet. 1994;343(8891):213-6. [DOI via Crossref]   
17. Kakuda K, Ikematsu H, Chong WLY, Hayashi J, Kashiwagi S. Molecular epidemiology of human T lymphotropic virus type 1 transmission in Okinawa, Japan. The American journal of tropical medicine and hygiene. 2002;66(4):404-8. [Pubmed]   
18. Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. Journal of virology. 1992;66(4):2288-95. [Pubmed]    [PMC Free Fulltext]   
19. Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. International journal of immunopharmacology. 1996;18(10):529-43. [DOI via Crossref]   
20. Nerurkar VR, Song K-J, Saitou N, Melland RR, Yanagihara R. Interfamilial and intrafamilial genomic diversity and molecular phylogeny of human T-cell lymphotropic virus type I from Papua New Guinea and the Solomon Islands. Virology. 1993;196(2): 506-13. [DOI via Crossref]    [Pubmed]   
21. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma. British journal of haematology. 1991;79(3):428-37. [DOI via Crossref]    [Pubmed]   
22. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-92. [Pubmed]   
23. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68. [DOI via Crossref]    [Pubmed]   
24. Mozaheb Z. Rare Presentation of Anaplastic Large Cell Lymphoma and HTLV1 Positivity: A Case Report and Review. Jacobs Journal of Hematology. 2015;1(3):16.
25. Gill PS, Harrington Jr W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, et al. Treatment of adult T-cell leukemia�lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine. 1995;332(26):1744-8. [DOI via Crossref]    [Pubmed]   
26. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. Journal of Clinical Oncology. 2009;27(3):453-9. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

How to Cite this Article
Pubmed Style

Zahra Mozaheb. Epidemiology of HTLV1 Associated Lymphoma. Ulutas Med J. 2016; 2(1): 77-81. doi:10.5455/umj.20160216043925

Web Style

Zahra Mozaheb. Epidemiology of HTLV1 Associated Lymphoma. https://www.ulutasmedicaljournal.com/?mno=218539 [Access: March 26, 2023]. doi:10.5455/umj.20160216043925

AMA (American Medical Association) Style

Zahra Mozaheb. Epidemiology of HTLV1 Associated Lymphoma. Ulutas Med J. 2016; 2(1): 77-81. doi:10.5455/umj.20160216043925


Vancouver/ICMJE Style

Zahra Mozaheb. Epidemiology of HTLV1 Associated Lymphoma. Ulutas Med J. (2016), [cited March 26, 2023]; 2(1): 77-81. doi:10.5455/umj.20160216043925


Harvard Style

Zahra Mozaheb (2016) Epidemiology of HTLV1 Associated Lymphoma. Ulutas Med J, 2 (1), 77-81. doi:10.5455/umj.20160216043925


Turabian Style

Zahra Mozaheb. 2016. Epidemiology of HTLV1 Associated Lymphoma. THE ULUTAS MEDICAL JOURNAL, 2 (1), 77-81. doi:10.5455/umj.20160216043925


Chicago Style

Zahra Mozaheb. "Epidemiology of HTLV1 Associated Lymphoma." THE ULUTAS MEDICAL JOURNAL 2 (2016), 77-81. doi:10.5455/umj.20160216043925


MLA (The Modern Language Association) Style

Zahra Mozaheb. "Epidemiology of HTLV1 Associated Lymphoma." THE ULUTAS MEDICAL JOURNAL 2.1 (2016), 77-81. Print. doi:10.5455/umj.20160216043925


APA (American Psychological Association) Style

Zahra Mozaheb (2016) Epidemiology of HTLV1 Associated Lymphoma. THE ULUTAS MEDICAL JOURNAL, 2 (1), 77-81. doi:10.5455/umj.20160216043925


Author LoginReviewer LoginAbout PublisherEditorial PoliciesPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information
Copyright © 2023 THE ULUTAS MEDICAL JOURNAL All Rights Reserved. Subject to change without notice from or liability to THE ULUTAS MEDICAL JOURNAL.
For best results, please use Internet Explorer or Google Chrome

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.